Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 8 | 2024 | 870 | 1.480 |
Why?
|
Granulosa Cell Tumor | 1 | 2023 | 77 | 0.810 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2023 | 118 | 0.750 |
Why?
|
Vulvar Neoplasms | 2 | 2021 | 263 | 0.700 |
Why?
|
Fallopian Tube Diseases | 1 | 2020 | 60 | 0.690 |
Why?
|
Diverticulitis | 1 | 2022 | 185 | 0.660 |
Why?
|
Infertility, Female | 3 | 2020 | 760 | 0.650 |
Why?
|
Molecular Imaging | 2 | 2016 | 815 | 0.640 |
Why?
|
Appendicitis | 2 | 2022 | 675 | 0.600 |
Why?
|
Lymph Nodes | 6 | 2020 | 3466 | 0.580 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4876 | 0.570 |
Why?
|
Patient Positioning | 2 | 2016 | 326 | 0.560 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2022 | 2010 | 0.550 |
Why?
|
Endometrial Neoplasms | 3 | 2021 | 1366 | 0.530 |
Why?
|
Femoral Nerve | 1 | 2016 | 42 | 0.530 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36426 | 0.520 |
Why?
|
Radiology | 5 | 2022 | 2113 | 0.510 |
Why?
|
Ureter | 2 | 2024 | 367 | 0.490 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1121 | 0.490 |
Why?
|
Urologic Diseases | 1 | 2016 | 247 | 0.440 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.430 |
Why?
|
Placenta Accreta | 1 | 2016 | 237 | 0.420 |
Why?
|
Laparoscopy | 2 | 2024 | 2035 | 0.410 |
Why?
|
Crohn Disease | 4 | 2019 | 2279 | 0.390 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20570 | 0.380 |
Why?
|
Cryosurgery | 1 | 2016 | 474 | 0.370 |
Why?
|
Diagnostic Imaging | 6 | 2021 | 3530 | 0.360 |
Why?
|
Urinary Bladder | 1 | 2016 | 1152 | 0.340 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.330 |
Why?
|
Prostatic Neoplasms | 4 | 2020 | 11118 | 0.290 |
Why?
|
Positron-Emission Tomography | 4 | 2022 | 6485 | 0.290 |
Why?
|
Femoral Fractures | 1 | 2011 | 375 | 0.290 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.270 |
Why?
|
Ultrasonography | 6 | 2024 | 5972 | 0.270 |
Why?
|
Diphosphonates | 1 | 2011 | 636 | 0.270 |
Why?
|
Uterus | 3 | 2020 | 649 | 0.260 |
Why?
|
Image Enhancement | 1 | 2016 | 2885 | 0.260 |
Why?
|
Diagnosis, Differential | 14 | 2024 | 12974 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.240 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2645 | 0.240 |
Why?
|
Radiopharmaceuticals | 7 | 2022 | 2651 | 0.240 |
Why?
|
Nanoparticles | 1 | 2016 | 1959 | 0.240 |
Why?
|
Genital Neoplasms, Female | 2 | 2023 | 532 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.230 |
Why?
|
Ablation Techniques | 2 | 2018 | 248 | 0.230 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2016 | 187 | 0.230 |
Why?
|
Contrast Media | 7 | 2019 | 5311 | 0.230 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 795 | 0.220 |
Why?
|
Kidney | 2 | 2016 | 7048 | 0.220 |
Why?
|
Ureteral Diseases | 1 | 2023 | 63 | 0.220 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1922 | 0.220 |
Why?
|
Kidney Neoplasms | 4 | 2024 | 4249 | 0.220 |
Why?
|
Ureteral Neoplasms | 1 | 2024 | 106 | 0.220 |
Why?
|
Hysterosalpingography | 2 | 2020 | 26 | 0.220 |
Why?
|
Urography | 1 | 2024 | 315 | 0.210 |
Why?
|
Pelvis | 3 | 2023 | 732 | 0.210 |
Why?
|
Urinary Bladder Diseases | 1 | 2023 | 167 | 0.210 |
Why?
|
Humans | 68 | 2024 | 761504 | 0.210 |
Why?
|
Female | 45 | 2024 | 392644 | 0.200 |
Why?
|
Societies, Medical | 6 | 2024 | 3905 | 0.200 |
Why?
|
Polyps | 1 | 2024 | 200 | 0.200 |
Why?
|
Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.200 |
Why?
|
Medulloblastoma | 3 | 2012 | 678 | 0.190 |
Why?
|
Vaginal Neoplasms | 1 | 2021 | 104 | 0.180 |
Why?
|
Menstrual Hygiene Products | 1 | 2020 | 20 | 0.180 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1200 | 0.180 |
Why?
|
Lymphatic Metastasis | 3 | 2020 | 2915 | 0.180 |
Why?
|
Peer Review | 1 | 2022 | 217 | 0.180 |
Why?
|
Radiography | 4 | 2022 | 6965 | 0.170 |
Why?
|
Abdomen | 3 | 2022 | 1128 | 0.170 |
Why?
|
Neoplasm Staging | 6 | 2024 | 11121 | 0.170 |
Why?
|
Sensitivity and Specificity | 7 | 2022 | 14666 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2024 | 2020 | 0.170 |
Why?
|
Faculty | 1 | 2022 | 384 | 0.160 |
Why?
|
Jaundice | 1 | 2019 | 94 | 0.160 |
Why?
|
Digestive System Diseases | 1 | 2020 | 151 | 0.160 |
Why?
|
Incidental Findings | 1 | 2024 | 697 | 0.160 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2018 | 33 | 0.160 |
Why?
|
Uterine Hemorrhage | 1 | 2020 | 240 | 0.160 |
Why?
|
Menstruation | 1 | 2020 | 307 | 0.160 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 247 | 0.150 |
Why?
|
Neoplasms | 5 | 2020 | 22170 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2020 | 4320 | 0.150 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 15266 | 0.150 |
Why?
|
Ultrasonography, Doppler | 2 | 2019 | 462 | 0.150 |
Why?
|
Endometrium | 2 | 2020 | 403 | 0.150 |
Why?
|
Polyarteritis Nodosa | 1 | 2018 | 70 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 641 | 0.150 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2790 | 0.150 |
Why?
|
Triage | 1 | 2024 | 986 | 0.140 |
Why?
|
Cysts | 1 | 2022 | 681 | 0.140 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2019 | 258 | 0.140 |
Why?
|
Tuberculosis, Urogenital | 1 | 2016 | 9 | 0.140 |
Why?
|
Temporal Arteries | 1 | 2018 | 154 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 732 | 0.140 |
Why?
|
Patients | 1 | 2023 | 907 | 0.140 |
Why?
|
Rectal Fistula | 1 | 2017 | 75 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1096 | 0.130 |
Why?
|
Cerebellar Neoplasms | 2 | 2012 | 586 | 0.130 |
Why?
|
Algorithms | 1 | 2016 | 14031 | 0.130 |
Why?
|
Holography | 1 | 2016 | 80 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 100 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 711 | 0.120 |
Why?
|
Counseling | 1 | 2023 | 1547 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 278 | 0.120 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 548 | 0.120 |
Why?
|
Testis | 1 | 2018 | 794 | 0.120 |
Why?
|
Health Literacy | 1 | 2020 | 444 | 0.120 |
Why?
|
Tissue Adhesives | 1 | 2016 | 173 | 0.120 |
Why?
|
Tuberous Sclerosis | 1 | 2022 | 1030 | 0.120 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2015 | 88 | 0.120 |
Why?
|
Urogenital Neoplasms | 1 | 2015 | 131 | 0.120 |
Why?
|
Respiratory System Agents | 1 | 2014 | 30 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 9000 | 0.110 |
Why?
|
Cystic Fibrosis | 2 | 2014 | 1285 | 0.110 |
Why?
|
Pathology | 1 | 2016 | 270 | 0.110 |
Why?
|
Aminophenols | 1 | 2014 | 87 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
Urinary Incontinence | 1 | 2017 | 489 | 0.100 |
Why?
|
Fibrosis | 1 | 2019 | 2049 | 0.100 |
Why?
|
Evidence-Based Medicine | 3 | 2024 | 3688 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 532 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 833 | 0.100 |
Why?
|
Breast Feeding | 1 | 2020 | 1359 | 0.100 |
Why?
|
Uterine Neoplasms | 2 | 2020 | 1420 | 0.100 |
Why?
|
Sternotomy | 1 | 2013 | 128 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1085 | 0.100 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 552 | 0.100 |
Why?
|
Conscious Sedation | 1 | 2016 | 532 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2160 | 0.100 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 605 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 320 | 0.090 |
Why?
|
Acute Disease | 1 | 2022 | 7237 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.090 |
Why?
|
Retrospective Studies | 13 | 2024 | 80636 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 728 | 0.090 |
Why?
|
Male | 25 | 2024 | 360804 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2065 | 0.090 |
Why?
|
Quinolones | 1 | 2014 | 378 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1551 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 962 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2018 | 1958 | 0.090 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1410 | 0.080 |
Why?
|
Boronic Acids | 2 | 2011 | 915 | 0.080 |
Why?
|
X-Ray Microtomography | 1 | 2011 | 456 | 0.080 |
Why?
|
Middle Aged | 16 | 2024 | 220895 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 379 | 0.080 |
Why?
|
Quinazolines | 2 | 2012 | 1371 | 0.080 |
Why?
|
Aged | 15 | 2024 | 169289 | 0.080 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 358 | 0.080 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2011 | 396 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1496 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2400 | 0.070 |
Why?
|
Ataxia | 1 | 2010 | 306 | 0.070 |
Why?
|
Consensus | 3 | 2024 | 3123 | 0.070 |
Why?
|
Pyrazines | 2 | 2011 | 1201 | 0.070 |
Why?
|
Prognosis | 3 | 2017 | 29625 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2298 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1206 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2928 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1302 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7390 | 0.070 |
Why?
|
Adult | 15 | 2024 | 221177 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 754 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2942 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2947 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1914 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3080 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4652 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1125 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7594 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1400 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3598 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5821 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13380 | 0.060 |
Why?
|
Pregnancy | 4 | 2020 | 29874 | 0.060 |
Why?
|
Tumor Burden | 3 | 2019 | 1893 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2019 | 64680 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 141 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 1222 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20098 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1881 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2523 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2020 | 24 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2822 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3164 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15842 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 154 | 0.040 |
Why?
|
Menstruation Disturbances | 1 | 2020 | 143 | 0.040 |
Why?
|
United States | 6 | 2024 | 72334 | 0.040 |
Why?
|
Pyrimidines | 1 | 2011 | 3028 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2019 | 397 | 0.040 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2018 | 34 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 397 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 551 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13639 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 457 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 50 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 2018 | 203 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2606 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2024 | 782 | 0.040 |
Why?
|
Time Factors | 2 | 2016 | 39967 | 0.040 |
Why?
|
Education | 1 | 2020 | 537 | 0.040 |
Why?
|
Leukocytosis | 1 | 2018 | 251 | 0.030 |
Why?
|
Hematuria | 1 | 2018 | 233 | 0.030 |
Why?
|
Adolescent | 7 | 2020 | 88319 | 0.030 |
Why?
|
Cholestasis | 1 | 2019 | 378 | 0.030 |
Why?
|
Epididymis | 1 | 2018 | 228 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58976 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2017 | 231 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2024 | 3595 | 0.030 |
Why?
|
Receptors, Phospholipase A2 | 1 | 2015 | 33 | 0.030 |
Why?
|
Animals | 7 | 2018 | 168459 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2016 | 177 | 0.030 |
Why?
|
Flank Pain | 1 | 2015 | 43 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2019 | 5869 | 0.030 |
Why?
|
Endosonography | 1 | 2019 | 609 | 0.030 |
Why?
|
Leiomyoma | 1 | 2020 | 636 | 0.030 |
Why?
|
Nepal | 1 | 2016 | 305 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39106 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 775 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 803 | 0.030 |
Why?
|
Gelatin | 1 | 2016 | 220 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2016 | 15631 | 0.030 |
Why?
|
Biological Evolution | 1 | 2020 | 1071 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 863 | 0.030 |
Why?
|
Granuloma | 1 | 2016 | 328 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4575 | 0.030 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6766 | 0.030 |
Why?
|
Blotting, Western | 2 | 2012 | 5035 | 0.030 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2020 | 803 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1008 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 709 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2295 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1626 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 784 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1530 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2019 | 1071 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9280 | 0.030 |
Why?
|
Proteinuria | 1 | 2015 | 607 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2016 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2803 | 0.030 |
Why?
|
Mice | 6 | 2018 | 81525 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2416 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11076 | 0.020 |
Why?
|
Quail | 1 | 2011 | 40 | 0.020 |
Why?
|
Regeneration | 1 | 2020 | 1511 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3341 | 0.020 |
Why?
|
Chorioallantoic Membrane | 1 | 2011 | 50 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1118 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2171 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1618 | 0.020 |
Why?
|
Lameness, Animal | 1 | 2010 | 7 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3514 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2020 | 1868 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.020 |
Why?
|
Sputum | 1 | 2012 | 506 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1642 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18252 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2013 | 432 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 929 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74206 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4915 | 0.020 |
Why?
|
Fertilization in Vitro | 1 | 2016 | 1292 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 876 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 59243 | 0.020 |
Why?
|
Developing Countries | 1 | 2020 | 2885 | 0.020 |
Why?
|
Gait Disorders, Neurologic | 1 | 2010 | 240 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2827 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2010 | 718 | 0.020 |
Why?
|
Stem Cells | 1 | 2020 | 3522 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8529 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3826 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1720 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3416 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2254 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3357 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1675 | 0.020 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3579 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7967 | 0.010 |
Why?
|
Cerebellum | 1 | 2011 | 1501 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12795 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6132 | 0.010 |
Why?
|
Pain | 1 | 2018 | 5073 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2932 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2831 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 2243 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22176 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2557 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8320 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16981 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9539 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11742 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.010 |
Why?
|
Child | 2 | 2019 | 80153 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23995 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15732 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41487 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5305 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10445 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9486 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8547 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14414 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13506 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 54425 | 0.000 |
Why?
|